New and emerging treatments for major depressive disorder

Sprouts of hope for treatment resistant depression?

Kirsten Lawson summarises a new ‘state of the art review’ in the BMJ which focuses on novel and emerging pharmacotherapy and neuromodulation for people with ‘treatment resistant depression’.

[read the full story...]

Using the highs to combat the lows: ketamine-assisted therapy for anxiety and depression

ketamine

In her debut blog, Gabrielle Williams reviews a US study on the safety and effectiveness of ketamine-assisted therapy (a digital intervention combining psychotherapy, journaling and ketamine) for moderate to severe anxiety and depression.

[read the full story...]

Psilocybin for ‘treatment-resistant depression’: an island of hope in an ocean of uncertainty?

sinitta-leunen-08yfmU-PQUU-unsplash

In this blog, UCL MSc students consider an RCT published in the New England Journal of Medicine, which suggests that psilocybin-assisted psychotherapy may help reduce depression in people with severe and enduring illness, but side effects are common and more research is needed to look into longer term effects.

[read the full story...]

Psychedelics-assisted psychotherapy for alcohol use disorder: room for more evidence

zulian-firmansyah-sEUAJeFn5mE-unsplash

In her debut blog, Heidi Stevens reviews a recent US randomised controlled trial on psilocybin-assisted psychotherapy for adults with alcohol use disorder, which leaves us with more questions than answers.

[read the full story...]

Ketamine and suicidal ideation: French trial finds modest short-term effects

Ketamine.,Ketamine,Pills,In,Rx,Prescription,Drug,Bottle

Anya Borissova reviews a French trial that claims to be evidence that “ketamine is rapid, safe in the short term, and has persistent benefits for acute care in suicidal patients”.

[read the full story...]

How could MDMA-assisted and psilocybin-assisted psychotherapy help people with depression and PTSD?

emma-miller-1Qr5Lie0Ix0-unsplash

Anya Borissova and Philip Brooks consider a recent review exploring MDMA-assisted psychotherapy and psilocybin-assisted psychotherapy for trauma-related mental health difficulties.

[read the full story...]

Ketamine “shows promise” as an anti-suicidal ideation agent, but will this promise ever be realised?

sinitta-leunen-aFXiQMUi2zA-unsplash

Rosalind McAlpine and Karel Kieslich summarise a recent systematic review which focuses on the rapid anti-suicidal ideation effect of ketamine.

[read the full story...]

Can ketamine metabolites and gamma power help predict clinical response for ‘treatment resistant depression’?

girl-with-red-hat-r4A-lJTgXQg-unsplash

Anya Borissova summarises a recent randomised placebo-controlled trial that evaluated ketamine metabolites, clinical response, and gamma power for major depression.

[read the full story...]

Turn on, or tune out? Is psilocybin assisted therapy close to becoming a first-line treatment for depression?

reproductive-health-supplies-coalition-V4pVBEHKPo0-unsplash

James Rucker and Sameer Jauhar summarise a recent RCT on the effectiveness of psilocybin assisted therapy versus escitalopram assisted therapy for major depressive disorder.

[read the full story...]

Patients’ experience of ketamine treatment for depression: the ‘Ketamine and me’ project

shutterstock_562050361

In her debut blog, Harmony Jiang reviews a recent qualitative study exploring patients’ experience and response to ketamine treatment for depression.

[read the full story...]